OpGen Announced 1-for-10 Reverse Stock Split

Core Points - OpGen, Inc. has announced a 1-for-10 reverse stock split of its common stock, effective at 12:01 a.m. EST on May 20, 2024, to comply with Nasdaq's minimum bid price requirement of $1.00 per share [1][2] - The reverse stock split will reduce the number of outstanding shares from approximately 12,624,902 to about 1,262,490 shares, with no change in par value [3] - No fractional shares will be issued; any fractional shares will be rounded up to the nearest whole share [4] Company Information - OpGen, Inc. is a precision medicine company focused on molecular diagnostics and bioinformatics to combat infectious diseases, providing solutions that improve patient outcomes and reduce the spread of multidrug-resistant microorganisms [6]